References
- Akpan A, Morgan R. 2002. Oral candidiasis. Postgrad Med J. 78(922):455–459. https://doi.org/10.1136/pmj.78.922.455.
- Arendrup MC, Fuursted K, Gahrn-Hansen B, Jensen IM, Knudsen JD, Lundgren B, Schønheyder HC, Tvede M. 2005. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol. 43(9):4434–4440.
- Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: human fungal infections. Sci Transl Med. 4(165):165rv13–165rv13.
- Cannon RD, Lamping E, Holmes AR, Niimi K, Tanabe K, Niimi M, Monk BC. 2007. Candida albicans drug resistance–another way to cope with stress. Microbiology. 153(10):3211–3217.
- Dabas PS. 2013. An approach to etiology, diagnosis and management of different types of candidiasis. J Yeast Fungal Res. 4(6):63–74.
- Dzoyem JP, Tchuenguem RT, Kuiate JR, Teke GN, Kechia FA, Kuete V. 2014. In vitro and in vivo antifungal activities of selected Cameroonian dietary spices. BMC Complement Altern Med. 14(1):58. https://doi.org/10.1186/1472-6882-14-58.
- Enoch DA, Ludlam HA, Brown NM. 2006. Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol. 55(7):809–818.
- Espinel-Ingroff A, Canton E, Peman J, Rinaldi MG, Fothergill AW. 2009. Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. and other yeasts. J Clin Microbiol. 47(9):2766–2771.
- Javed S, Shahid AA, Haider MS, Umeera A, Ahmad R, Mushtaq S. 2012. Nutritional, phytochemical potential and pharmacological evaluation of Nigella sativa (Kalonji) and Trachyspermum ammi (Ajwain). J Med Plants Res. 6(5):768–775.
- Kourkoumpetis TK, Velmahos GC, Ziakas PD, Tampakakis E, Manolakaki D, Coleman JJ, Mylonakis E. 2011. The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients. Mycopathologia. 171(2):85–91.
- Kumar S, Kalam K, Ali S, Siddiqi S, Baqi S. 2014. Frequency, clinical presentation and microbiological spectrum of candidemia in a tertiary care center in Karachi. J Pakistan Med Assoc. 35:13–27.
- Noguchi Y, Fukuda K, Matsushima A, Haishi D, Hiroto M, Kodera Y, Nishimura H, Inada Y. 1999. Inhibition of Df-protease associated with allergic diseases by polyphenol. J Agric Food Chem. 47(8):2969–2972.
- Shrivastava V, Shrivastava G, Sharma R, Mahajan N, Sharma V, Bhardwaj U. 2012. Anti-microbial potential of Ajwain (Trachyspermum copticum): An Immense Medical Spice. J Pharm Res. 5(7):3837–3840.
- Palese E, Nudo M, Zino G, Devirgiliis V, Carbotti M, Cinelli E, Rodio DM, Bressan A, Prezioso C, Ambrosi C, et al. 2018. Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation. Int J Immunopathol Pharmacol. 32:205873841878136. 2058738418781368.
- Ranjan B, Singhal M, Ravindra S, Kumar SA, Ajay T. 2011. Medicinal uses of Trachyspermum ammi: a review. Pharmacologyonline. 2:477–485.
- Sasidharan S, Zuraini Z, Latha LY, Suryani S. 2008. Fungicidal Effect and Oral Acute Toxicity of Root Extract Pharm Biol. 46(4):261–265. https://doi.org/10.1080/13880200701740858.
- Segal E, Frenkel M. 2018. Experimental In Vivo Models of Candidiasis. JoF. 4(1):21.
- Sharma B, Kumar P, Joshi S. C. 2011. Topical treatment of dermatophytic lesion on mice (Mus musculus) model. Indian J Microbiol. 51(2):217–222.
- Sharifzadeh A, Khosravi AR, Shokri H, Sharafi G. 2015. Antifungal effect of Trachyspermum ammi against susceptible and fluconazole-resistant strains of Candida albicans. J Mycol Med. 25(2):143–150.
- Wisetsai A, Lekphrom R, Schevenels FT. A novel cyclohexenone from Trachyspermum roxburghianum. Nat Prod Res. 2018 Nov 2;32(21):2499–504.
- Yapar N. 2014. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 10:95–105.